APO Research
Talk to an analyst

APO RESEARCH · REPORT

Narcolepsy Drug

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.

The narcolepsy drug is the drug to treat narcolepsy.

Selected research

Industry Growth & Trends

Global Narcolepsy Drug Industry Growth and Trends Forecast to 2032

2 January 202679 pages

Choose your research edition.

Industry ResearchNarcolepsy Drug Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Narcolepsy Drug Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Narcolepsy Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Narcolepsy Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Narcolepsy Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.

The narcolepsy drug is the drug to treat narcolepsy.

Market competition is concentrated. Jazz Pharmaceuticals, Teva Pharmaceutical, Novartis and Mylan. are the leaders of the industry, with about 91% market shares.

Read the full market overview

Europe is the largest consumption place, with a consumption market share nearly 58%. Following Europe, USA is the second largest consumption place with the consumption market share of 29%.

Report Scope

This report provides a structured, data-driven view of the global Narcolepsy Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Narcolepsy Drug market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Narcolepsy Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Narcolepsy Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Narcolepsy Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Narcolepsy Drug Market by Company

Jazz Pharmaceuticals

Teva Pharmaceutical

Novartis

Mylan

Narcolepsy Drug Segment by Type

Antioxidants Type

Stimulants Type

Others

Narcolepsy Drug Segment by Application

Daytime Extreme Sleepiness

Cataplexia

Others

Narcolepsy Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Narcolepsy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Narcolepsy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Narcolepsy Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Narcolepsy Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Narcolepsy Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antioxidants Type Table 2. Major Company of Stimulants Type Table 3. Major Company of Others Table 4. Global Narcolepsy Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Narcolepsy Drug Sales by Type (2021-2026) & (Kg) Table 6. Global Narcolepsy Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Narcolepsy Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Narcolepsy Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Narcolepsy Drug Price by Type (2021-2026) & (k USD/Kg) Table 10. Global Narcolepsy Drug Sales by Type (2027-2032) & (Kg) Table 11. Global Narcolepsy Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Narcolepsy Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Narcolepsy Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Narcolepsy Drug Price by Type (2027-2032) & (k USD/Kg) Table 15. North America Narcolepsy Drug Sales by Type (2021-2026) & (Kg) Table 16. North America Narcolepsy Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Narcolepsy Drug Sales by Type (2021-2026) & (Kg) Table 18. Europe Narcolepsy Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Narcolepsy Drug Sales by Type (2021-2026) & (Kg) Table 20. Asia-Pacific Narcolepsy Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Narcolepsy Drug Sales by Type (2021-2026) & (Kg) Table 22. Latin America Narcolepsy Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Narcolepsy Drug Sales by Type (2021-2026) & (Kg) Table 24. Middle East and Africa Narcolepsy Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Narcolepsy Drug Industry Trends Table 26. Narcolepsy Drug Industry Drivers Table 27. Narcolepsy Drug Industry Opportunities and Challenges Table 28. Narcolepsy Drug Industry Restraints Table 29. Global Narcolepsy Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Narcolepsy Drug Revenue Market Share by Company (2021-2026) Table 31. Global Narcolepsy Drug Sales by Company (2021-2026) & (Kg) Table 32. Global Narcolepsy Drug Sales Share by Company (2021-2026) Table 33. Global Narcolepsy Drug Market Price by Company (2021-2026) & (k USD/Kg) Table 34. Global Narcolepsy Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Narcolepsy Drug Major Company Production Sites and Headquarters Table 36. Global Narcolepsy Drug Company, Product Type & Application Table 37. Global Narcolepsy Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Narcolepsy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Narcolepsy Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Narcolepsy Drug Sales by Region (2021-2026) & (Kg) Table 42. Global Narcolepsy Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Narcolepsy Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Narcolepsy Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Narcolepsy Drug Sales (Kg), Value (US$ Million), Price (k USD/Kg) and Gross Margin (2021-2026) Table 46. Global Narcolepsy Drug Sales by Region (2027-2032) & (Kg) Table 47. Global Narcolepsy Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Narcolepsy Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Narcolepsy Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Narcolepsy Drug Sales (Kg), Value (US$ Million), Price (k USD/Kg) and Gross Margin (2027-2032) Table 51. Global Narcolepsy Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Narcolepsy Drug Sales by Application (2021-2026) & (Kg) Table 53. Global Narcolepsy Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Narcolepsy Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Narcolepsy Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Narcolepsy Drug Price by Application (2021-2026) & (k USD/Kg) Table 57. Global Narcolepsy Drug Sales by Application (2027-2032) & (Kg) Table 58. Global Narcolepsy Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Narcolepsy Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Narcolepsy Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Narcolepsy Drug Price by Application (2027-2032) & (k USD/Kg) Table 62. North America Narcolepsy Drug Sales by Application (2021-2026) & (Kg) Table 63. North America Narcolepsy Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Narcolepsy Drug Sales by Application (2021-2026) & (Kg) Table 65. Europe Narcolepsy Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Narcolepsy Drug Sales by Application (2021-2026) & (Kg) Table 67. Asia-Pacific Narcolepsy Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Narcolepsy Drug Sales by Application (2021-2026) & (Kg) Table 69. Latin America Narcolepsy Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Narcolepsy Drug Sales by Application (2021-2026) & (Kg) Table 71. Middle East and Africa Narcolepsy Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Jazz Pharmaceuticals Company Information Table 73. Jazz Pharmaceuticals Business Overview Table 74. Jazz Pharmaceuticals Narcolepsy Drug Sales (Kg), Revenue (US$ Million), Price (k USD/Kg) and Gross Margin (2021-2026) Table 75. Jazz Pharmaceuticals Narcolepsy Drug Product Portfolio Table 76. Jazz Pharmaceuticals Recent Development Table 77. Teva Pharmaceutical Company Information Table 78. Teva Pharmaceutical Business Overview Table 79. Teva Pharmaceutical Narcolepsy Drug Sales (Kg), Revenue (US$ Million), Price (k USD/Kg) and Gross Margin (2021-2026) Table 80. Teva Pharmaceutical Narcolepsy Drug Product Portfolio Table 81. Teva Pharmaceutical Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Narcolepsy Drug Sales (Kg), Revenue (US$ Million), Price (k USD/Kg) and Gross Margin (2021-2026) Table 85. Novartis Narcolepsy Drug Product Portfolio Table 86. Novartis Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Narcolepsy Drug Sales (Kg), Revenue (US$ Million), Price (k USD/Kg) and Gross Margin (2021-2026) Table 90. Mylan Narcolepsy Drug Product Portfolio Table 91. Mylan Recent Development Table 92. North America Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 93. North America Narcolepsy Drug Sales by Country (2021-2026) & (Kg) Table 94. North America Narcolepsy Drug Sales Market Share by Country (2021-2026) Table 95. North America Narcolepsy Drug Sales Forecast by Country (2027-2032) & (Kg) Table 96. North America Narcolepsy Drug Sales Market Share Forecast by Country (2027-2032) Table 97. North America Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Narcolepsy Drug Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Narcolepsy Drug Market Share by Country (2021-2026) Table 100. North America Narcolepsy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Narcolepsy Drug Market Share Forecast by Country (2027-2032) Table 102. Europe Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 103. Europe Narcolepsy Drug Sales by Country (2021-2026) & (Kg) Table 104. Europe Narcolepsy Drug Sales Market Share by Country (2021-2026) Table 105. Europe Narcolepsy Drug Sales Forecast by Country (2027-2032) & (Kg) Table 106. Europe Narcolepsy Drug Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Narcolepsy Drug Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Narcolepsy Drug Market Share by Country (2021-2026) Table 110. Europe Narcolepsy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Narcolepsy Drug Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Narcolepsy Drug Sales by Country (2021-2026) & (Kg) Table 114. Asia-Pacific Narcolepsy Drug Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Narcolepsy Drug Sales Forecast by Country (2027-2032) & (Kg) Table 116. Asia-Pacific Narcolepsy Drug Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Narcolepsy Drug Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Narcolepsy Drug Market Share by Country (2021-2026) Table 120. Asia-Pacific Narcolepsy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Narcolepsy Drug Market Share Forecast by Country (2027-2032) Table 122. Latin America Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 123. Latin America Narcolepsy Drug Sales by Country (2021-2026) & (Kg) Table 124. Latin America Narcolepsy Drug Sales Market Share by Country (2021-2026) Table 125. Latin America Narcolepsy Drug Sales Forecast by Country (2027-2032) & (Kg) Table 126. Latin America Narcolepsy Drug Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Narcolepsy Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Narcolepsy Drug Market Share by Country (2021-2026) Table 130. Latin America Narcolepsy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Narcolepsy Drug Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Narcolepsy Drug Sales by Country (2021-2026) & (Kg) Table 134. Middle East and Africa Narcolepsy Drug Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Narcolepsy Drug Sales Forecast by Country (2027-2032) & (Kg) Table 136. Middle East and Africa Narcolepsy Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Narcolepsy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Narcolepsy Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Narcolepsy Drug Market Share by Country (2021-2026) Table 140. Middle East and Africa Narcolepsy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Narcolepsy Drug Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Narcolepsy Drug Distributors List Table 145. Narcolepsy Drug Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Narcolepsy Drug Image Figure 2. Global Narcolepsy Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Narcolepsy Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Narcolepsy Drug Sales (2021-2032) & (Kg) Figure 5. Antioxidants Type Image Figure 6. Global Antioxidants Type Sales YoY Growth (2021-2032) & (Kg) Figure 7. Stimulants Type Image Figure 8. Global Stimulants Type Sales YoY Growth (2021-2032) & (Kg) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 11. Global Narcolepsy Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Narcolepsy Drug Market Share by Type 2025 VS 2032 Figure 13. North America Narcolepsy Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Narcolepsy Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Narcolepsy Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Narcolepsy Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Narcolepsy Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Narcolepsy Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Narcolepsy Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Narcolepsy Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Narcolepsy Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Narcolepsy Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Narcolepsy Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Daytime Extreme Sleepiness Image Figure 26. Global Daytime Extreme Sleepiness Sales YoY Growth (2021-2032) & (Kg) Figure 27. Cataplexia Image Figure 28. Global Cataplexia Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Narcolepsy Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Narcolepsy Drug Market Share by Application 2025 VS 2032 Figure 33. North America Narcolepsy Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Narcolepsy Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Narcolepsy Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Narcolepsy Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Narcolepsy Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Narcolepsy Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Narcolepsy Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Narcolepsy Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Narcolepsy Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Narcolepsy Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Narcolepsy Drug Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Narcolepsy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Narcolepsy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Narcolepsy Drug Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Narcolepsy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Narcolepsy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Narcolepsy Drug Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Narcolepsy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Narcolepsy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Narcolepsy Drug Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Narcolepsy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Narcolepsy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Narcolepsy Drug Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Narcolepsy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Narcolepsy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Narcolepsy Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Narcolepsy Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Antioxidants Type
  • Stimulants Type
  • Others
Applications
  • Daytime Extreme Sleepiness
  • Cataplexia
  • Others
Companies covered
  • Jazz Pharmaceuticals
  • Teva Pharmaceutical
  • Novartis
  • Mylan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Narcolepsy Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Narcolepsy Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Narcolepsy Drug Market by Type
  6. 1.3.1 Antioxidants Type
  7. 1.3.2 Stimulants Type
  8. 1.3.3 Others
  9. 1.4 Global Narcolepsy Drug Market Size by Type
  10. 1.4.1 Global Narcolepsy Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Narcolepsy Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Narcolepsy Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Narcolepsy Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Narcolepsy Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Narcolepsy Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Narcolepsy Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Narcolepsy Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Narcolepsy Drug Industry Trends
  2. 2.2 Narcolepsy Drug Industry Drivers
  3. 2.3 Narcolepsy Drug Industry Opportunities and Challenges
  4. 2.4 Narcolepsy Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Narcolepsy Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Narcolepsy Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Narcolepsy Drug Price (2021-2026)
  4. 3.4 Global Narcolepsy Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Narcolepsy Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Narcolepsy Drug Company, Product Type & Application
  7. 3.7 Global Narcolepsy Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Narcolepsy Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Narcolepsy Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Narcolepsy Drug Tier 1, Tier 2, and Tier 3
4 Narcolepsy Drug Regional Status and Outlook
  1. 4.1 Global Narcolepsy Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Narcolepsy Drug Historic Market Size by Region
  3. 4.2.1 Global Narcolepsy Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Narcolepsy Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Narcolepsy Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Narcolepsy Drug Forecasted Market Size by Region
  7. 4.3.1 Global Narcolepsy Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Narcolepsy Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Narcolepsy Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Narcolepsy Drug by Application
  1. 5.1 Narcolepsy Drug Market by Application
  2. 5.1.1 Daytime Extreme Sleepiness
  3. 5.1.2 Cataplexia
  4. 5.1.3 Others
  5. 5.2 Global Narcolepsy Drug Market Size by Application
  6. 5.2.1 Global Narcolepsy Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Narcolepsy Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Narcolepsy Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Narcolepsy Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Narcolepsy Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Narcolepsy Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Narcolepsy Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Narcolepsy Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jazz Pharmaceuticals
  2. 6.1.1 Jazz Pharmaceuticals Company Information
  3. 6.1.2 Jazz Pharmaceuticals Business Overview
  4. 6.1.3 Jazz Pharmaceuticals Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jazz Pharmaceuticals Narcolepsy Drug Product Portfolio
  6. 6.1.5 Jazz Pharmaceuticals Recent Developments
  7. 6.2 Teva Pharmaceutical
  8. 6.2.1 Teva Pharmaceutical Company Information
  9. 6.2.2 Teva Pharmaceutical Business Overview
  10. 6.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Narcolepsy Drug Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Narcolepsy Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Narcolepsy Drug Product Portfolio
  24. 6.4.5 Mylan Recent Developments
7 North America by Country
  1. 7.1 North America Narcolepsy Drug Sales by Country
  2. 7.1.1 North America Narcolepsy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Narcolepsy Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Narcolepsy Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Narcolepsy Drug Market Size by Country
  6. 7.2.1 North America Narcolepsy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Narcolepsy Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Narcolepsy Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Narcolepsy Drug Sales by Country
  2. 8.1.1 Europe Narcolepsy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Narcolepsy Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Narcolepsy Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Narcolepsy Drug Market Size by Country
  6. 8.2.1 Europe Narcolepsy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Narcolepsy Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Narcolepsy Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Narcolepsy Drug Sales by Country
  2. 9.1.1 Asia-Pacific Narcolepsy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Narcolepsy Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Narcolepsy Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Narcolepsy Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Narcolepsy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Narcolepsy Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Narcolepsy Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Narcolepsy Drug Sales by Country
  2. 10.1.1 South America Narcolepsy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Narcolepsy Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Narcolepsy Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Narcolepsy Drug Market Size by Country
  6. 10.2.1 South America Narcolepsy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Narcolepsy Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Narcolepsy Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Narcolepsy Drug Sales by Country
  2. 11.1.1 Middle East and Africa Narcolepsy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Narcolepsy Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Narcolepsy Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Narcolepsy Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Narcolepsy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Narcolepsy Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Narcolepsy Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Narcolepsy Drug Value Chain Analysis
  2. 12.1.1 Narcolepsy Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Narcolepsy Drug Production Mode & Process
  7. 12.2 Narcolepsy Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Narcolepsy Drug Distributors
  10. 12.2.3 Narcolepsy Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst